AbbVie's Humira (adalimumab) receives first and only Health Canada approval for moderate to severe hidradenitis suppurativa

Health Canada

6 January 2016 - This follows approval from the FDA and the European Commission. Humira is now the first and only Health Canada-approved therapy for the treatment of adults living with hidradenitis suppurativa.

For more details, go to: http://www.newswire.ca/news-releases/abbvies-humira-adalimumab-receives-first-and-only-health-canada-approval-for-moderate-to-severe-hidradenitis-suppurativa-564353901.html

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Outcome , Medicine , Canada